Baseline cell cycle and immune profiles indicate CDK4/6 inhibitor response in metastatic HR + /HER2- breast cancer. [PDF]
Tzetzo SL +6 more
europepmc +1 more source
Prognostic immune markers in esophageal cancer patients managed with trimodal therapy. [PDF]
Farrugia MK +11 more
europepmc +1 more source
Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. [PDF]
Crawford KJ +11 more
europepmc +1 more source
NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. [PDF]
Giridharan T +20 more
europepmc +1 more source
Cardiac sarcoidosis — diagnostic difficulties
Małgorzata Poniatowska-Roszkowska +5 more
doaj +1 more source
Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models. [PDF]
Wu J +6 more
europepmc +1 more source
Perinatal Outcomes and Level of Labour Difficulty in Deliveries with Right and Left Foetal Position-A Preliminary Study. [PDF]
Witkiewicz M +10 more
europepmc +1 more source
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis. [PDF]
Hahnen E +37 more
europepmc +1 more source
Three-Layered Composite Scintillator Based on the Epitaxial Structures of YAG and LuAG Garnets Doped with Ce3+ and Sc3+ Impurities. [PDF]
Witkiewicz-Łukaszek S +11 more
europepmc +1 more source
Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy. [PDF]
O'Connor TN +6 more
europepmc +1 more source

